TwinBeech Capital’s Idexx Laboratories IDXX Stock Holding History

TwinBeech Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.62M	Buy	8,770 +8,263	+1,630%	+$4.63M	0.84%	39
2026 Q1	$285K	Buy	+507	New	+$325K	0.03%	463
2025 Q2	–	Sell	-23,712	Closed	-$9.96M	–	806
2025 Q1	$9.96M	Buy	+23,712	New	+$10.3M	0.18%	149
2024 Q3	–	Sell	-43,348	Closed	-$21.1M	–	764
2024 Q2	$21.1M	Sell	43,348 -60,185	-58%	-$30.2M	0.42%	80
2024 Q1	$55.9M	Buy	+103,533	New	+$56.6M	1.15%	17
2022 Q1	–	Sell	-806	Closed	-$531K	–	611
2021 Q4	$531K	Sell	806 -283	-26%	-$178K	0.03%	413
2021 Q3	$677K	Buy	+1,089	New	+$732K	0.05%	389
2021 Q2	–	Sell	-11,150	Closed	-$5.46M	–	539
2021 Q1	$5.46M	Buy	11,150 +9,245	+485%	+$4.63M	0.8%	28
2020 Q4	$952K	Buy	+1,905	New	+$852K	0.15%	181

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TwinBeech Capital's IDXX Position: Q2 2026 in Review

TwinBeech Capital increased its Idexx Laboratories (IDXX) stake by 1,630% in Q2 2026, buying an estimated $4.63M and bringing the position to 8,770 shares worth $4.62M. The position accounts for 0.84% of the portfolio, ranked #39.

TwinBeech Capital first reported a position in IDXX in Q4 2020 and has held it in 9 quarters since. The position peaked at $55.9M in Q1 2024. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

TwinBeech Capital held 8,770 shares of Idexx Laboratories worth $4.62M as of Q2 2026.
TwinBeech Capital bought 8,263 Idexx Laboratories shares in Q2 2026, an estimated $4.63M.
Idexx Laboratories made up 0.84% of TwinBeech Capital's portfolio in Q2 2026, its #39 holding.
TwinBeech Capital first reported a position in Idexx Laboratories in Q4 2020 and has held it in 9 quarters since.
TwinBeech Capital's Idexx Laboratories position peaked at $55.9M in Q1 2024.
1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.